Xi Li

2.5k citations
85 papers · 1.7k indexed · 1 hit paper · h-index 21
Topics
Antibiotic Resistance in Bacteria (13 papers)Ferroptosis and cancer prognosis (9 papers)Antibiotics Pharmacokinetics and Efficacy (5 papers)
Journals
ScienceSHILAP Revista de lepidopterologíaBiomaterials

In The Last Decade

Xi Li

78 papers receiving 1.7k citations

Hit Papers

A Variant of the HTRA1 Gene Increases Susceptibility to A...20062026201220192006200400600

Peers

Xi Li
Comparison fields: 5 of 123
  • Molecular Biology 677
  • Ophthalmology 514
  • Radiology, Nuclear Medicine and Imaging 346
  • Surgery 205
  • Pulmonary and Respiratory Medicine 159
Replace Lan Wang with:
Lan Wang China
Jiří Polívka Czechia
Saverio Candido Italy
George Hoppe United States
Agnès Boullier France
Lin Zhou China
Di Chen China
Stuart Friedrich United States
Shuai Zhang China
Ho‐Shik Kim South Korea
Xi Li relative to Lan Wang China Lan Wang's profile →
Citations per field
00.5×1.5×2.2×
Lan Wang · 1×
Citations per year

Countries citing papers authored by Xi Li

Since Specialization
Citations

This map shows the geographic impact of Xi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Li more than expected).

Fields of papers citing papers by Xi Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Li. The network helps show where Xi Li may publish in the future.

Co-authorship network of co-authors of Xi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Li. A scholar is included among the top collaborators of Xi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Li. Xi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 5
4 7
5 3
6 8
7 28
8 20
9 9
10 1
11 32
12 1
13 2
14 1
15 1
16 16
17 34
18 0
19 6
20 21

About Xi Li

Xi Li is a scholar working on Molecular Medicine, Endocrinology and Biological Psychiatry, having authored 85 papers that have together received 1.7k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (13 papers), Ferroptosis and cancer prognosis (9 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). The work is most often cited by research in Ophthalmology (514 citations), Radiology, Nuclear Medicine and Imaging (346 citations) and Molecular Medicine (65 citations). Xi Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Zhenglin Yang, Yu Zhao, Zongzhong Tong, Paul S. Bernstein, D. Joshua Cameron, Haoyu Chen, Kang Zhang, Viji Shridhar, Erik Pearson and Andrew T. DeWan. Their work appears in journals such as Science, SHILAP Revista de lepidopterología and Biomaterials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026